iShares US Medical Devices ETF
IHI

$59.07

0.54%

Market Cap: $5.52B

0

Funds holding %

of 6,710 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

57% more call options, than puts

Call options by funds: $20.2M | Put options by funds: $12.9M

7% less funds holding

Funds holding: 569 [Q1] → 530 (-39) [Q2]

15% less capital invested

Capital invested by funds: $2.5B [Q1] → $2.12B (-$383M) [Q2]

43% less first-time investments, than exits

New positions opened: 51 | Existing positions closed: 90

45% less repeat investments, than reductions

Existing positions increased: 123 | Existing positions reduced: 223

57% less funds holding in top 10

Funds holding in top 10: 7 [Q1] → 3 (-4) [Q2]

523.04% less ownership

Funds ownership: 563.65% [Q1] → 40.62% (-523.04%) [Q2]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for IHI.

See Analyst Rankings

Financial journalist opinion

Based on 4 articles about IHI published over the past 30 days

Zacks Investment Research

5 Best Top-Ranked ETFs of August With Room for More Upside

Investors may consider betting on top-ranked ETFs that emerged as winners in August to tap the ongoing trend.

5 Best Top-Ranked ETFs of August With Room for More Upside

CNBC Television

Final Trades: CME Group, Chubb, Berkshire Hathaway and the IHI

The Investment Committee give you their top stocks to watch for the second half.

Final Trades: CME Group, Chubb, Berkshire Hathaway and the IHI

Zacks Investment Research

ETF Winners of Q2 Earnings: 4 Must-See Charts

Let's delve into some of the best ETF charts of Q2 earnings.

ETF Winners of Q2 Earnings: 4 Must-See Charts

IHI: A Pricey P/E But Bullish Chart Setup

Health Care sector at 52-week highs, led by Eli Lilly. Hold rating on iShares U.S. Medical Devices ETF (IHI) due to high valuation and secular headwinds. IHI has strong chart setup but high valuation, concentration risk, and weak seasonal trends; resistance at $59, support at $53-$54.

IHI: A Pricey P/E But Bullish Chart Setup

Zacks Investment Research

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

The iShares U.S. Medical Devices ETF (IHI) was launched on 05/01/2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Medical Devices segment of the equity market.

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

Zacks Investment Research

5 Sector ETFs & Stocks to Benefit From May Inflation Report

US annual inflation rate slowed to 3.3% in May 2024, the lowest in three months, compared to 3.4% in April and forecasts of 3.4%.

5 Sector ETFs & Stocks to Benefit From May Inflation Report

IHI: Despite Steady Returns At Current Prices, ETF Is Fairly Valued

iShares U.S. Medical Devices ETF has underperformed in recent times. The healthcare sector is considered defensive, but medical devices may still be sensitive to economic downturns. IHI's present valuation is, in my opinion, fair (unlike at the end of 2021), but there are still concentration risks and little margin of safety in earnings growth numbers.

IHI: Despite Steady Returns At Current Prices, ETF Is Fairly Valued

Zacks Investment Research

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

Launched on 05/01/2006, the iShares U.S. Medical Devices ETF (IHI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Medical Devices segment of the equity market.

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

The All-Weather ETF Trifecta: 3 Funds to Buy and Hold Forever

Markets are increasingly volatile, making many wish they had taken the “Sell in May and Go Away” mantra to heart. Still, though some markets are lagging, there's a hidden opportunity: snag some of the best ETFs to buy and hold before it's too late.

The All-Weather ETF Trifecta: 3 Funds to Buy and Hold Forever

IHI Appoints Susan Ehrlich, CEO of Zuckerberg San Francisco General, to its Board of Directors

BOSTON--(BUSINESS WIRE)-- #IHIForum--The Institute for Healthcare Improvement (IHI) has announced that Susan Ehrlich, MD, MPP, has joined its Board of Directors.

IHI Appoints Susan Ehrlich, CEO of Zuckerberg San Francisco General, to its Board of Directors

See News Rankings